Real World Prostate Cancer Registry

Recruiting now

Conditions studied: Prostate Cancer

In brief

Prostate cancer is the most common cancer diagnosed in men in the USA with 268,490 cases diagnosed in 2022 constituting 27% of male cancers and 34,500 deaths (11%) occurred in same year.1 Prostate cancer is a very heterogeneous disease that has different presentations, molecular and pathological features, stages, and disease biology. The treatment options are dependent on the disease stage, its features, and the patient's condition and preferences. The disease outcome also varies significantly due to the previous heterogeneity of the features in addition to other social determinants of health. Therefore, it is critical to obtain real-world data that reflects the actual patterns of prostate cancer presentation, work up, management, and outcome. Real World Prostate Cancer Registry (RWPCR) aims at compiling real world data from patients presented with prostate cancer in the tristate area. The data collection will be prospective and longitudinal including patients' demographics and disease characteristics, work up, management, and outcome.

Key facts

Study ID: NCT06355336
Run by: Cincinnati Cancer Advisors
People needed: 1000
Starts: 2024-03-18
Expected to finish: 2034-03-18
Last updated by the study team: 2025-05-31

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

All patients with pathologically confirmed primary prostate cancer
Diagnosis since January 1st, 2023
Acceptance to sign the consent form
18 years old or older
Resident of Ohio, Kentucky or Indiana

You may not qualify if…

Having diagnosis of other cancer except squamous cell cancer of the skin
Refusal to sign a consent form.

Where it is running

Cincinnati Cancer Advisors — Cincinnati, Ohio, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.